TY - JOUR
T1 - Artificial intelligence and deep learning in ophthalmology
AU - Ting, Daniel Shu Wei
AU - Pasquale, Louis R.
AU - Peng, Lily
AU - Campbell, John Peter
AU - Lee, Aaron Y.
AU - Raman, Rajiv
AU - Tan, Gavin Siew Wei
AU - Schmetterer, Leopold
AU - Keane, Pearse A.
AU - Wong, Tien Yin
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields, achieving robust classification performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings. Nonetheless, there are also potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medicolegal issues, and physician and patient acceptance of the AI € black-box' algorithms. DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward.
AB - Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields, achieving robust classification performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings. Nonetheless, there are also potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medicolegal issues, and physician and patient acceptance of the AI € black-box' algorithms. DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward.
KW - glaucoma
KW - imaging
KW - public health
KW - retina
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85055474664&partnerID=8YFLogxK
U2 - 10.1136/bjophthalmol-2018-313173
DO - 10.1136/bjophthalmol-2018-313173
M3 - Review article
C2 - 30361278
AN - SCOPUS:85055474664
SN - 0007-1161
VL - 103
SP - 167
EP - 175
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 2
ER -